Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment

NCT04587622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Failure

Interventions

DRUG: Icenticaftor

Sponsor

Novartis Pharmaceuticals